2 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Active not recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow deflazacort: new trials by email Literature Review of deflazacort trials Research Report on deflazacort
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Deflazacort Vs. Prednisolone in Acute-stage ABPA Deflazacort, Prednisolone - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Active not recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 150 | 2020-01-15 | 2025-02-28 |
| A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I) Deflazacort - Limb-Girdle Muscular Dystrophy | Phase 3 | Terminated | PTC Therapeutics | 11 | 2019-10-31 | 2022-06-27 |
| A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD) Deflazacort - Duchenne Muscular Dystrophy | Phase 3 | Withdrawn | PTC Therapeutics | 2018-10-31 | 2019-06-21 | |
| Finding the Optimum Regimen for Duchenne Muscular Dystrophy Prednisone, Deflazacort - Duchenne Muscular Dystrophy | Phase 3 | Completed | University of Rochester | 196 | 2013-01-01 | 2022-08-12 |
| Deflazacort in Dysferlinopathies deflazacort, placebo - LGMD2B, Miyoshi Myopathy | Phase 2 / Phase 3 | Completed | Ludwig-Maximilians - University of Munich | 25 | 2003-09-01 | 2015-09-02 |
Muscular Dystrophies (2) · Muscular Dystrophy, Duchenne (2) · Aspergillosis, Allergic Bronchopulmonary (1) · Asthma (1) · Dysferlinopathy (1) · Limb-girdle muscular dystrophy, type 2B (1) · Miyoshi myopathy (1) · Muscular Dystrophies, Limb-Girdle (1) · Neuromuscular Diseases (1)
PTC Therapeutics (2) · Ludwig-Maximilians - University of Munich (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · University of Rochester (1)
Germany (3) · Canada (2) · United States (2) · Denmark (1) · France (1) · India (1) · Italy (1) · Norway (1) · Russia (1) · Sweden (1) · United Kingdom (1)
Cristobal Passalacqua, MD (1) · Francesco Bibbiani, MD (1) · Kate Bushby, MD (1) · Maggie C. Walter, MD (1) · Robert C. Griggs, MD (1)
PMID 23406536, PMID 34857536, PMID 35381069, PMID 42139655, PMID 42202243, PMID 42249273, PMID 42443978
U01NS061799 (1)